Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.42B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.74B |
| 5 |
Amazon
AMZN
|
+$1.27B |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.54B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$549M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$452M |
| 4 |
Stellantis
STLA
|
+$326M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$239M |
Sector Composition
| 1 | Technology | 29.05% |
| 2 | Healthcare | 11.56% |
| 3 | Financials | 10.8% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SI
3551
DELISTED
Silvergate Capital Corporation
SI
| $46K | ﹤0.01% |
66,102
-558,787
| -89% | -$389K |
|
|
AFMD
3552
DELISTED
Affimed
AFMD
| $45K | ﹤0.01% |
7,517
-8,304
| -52% | -$49.7K |
|
3553
Arhaus
ARHS
$1.55B
| $45K | ﹤0.01% |
4,289
+4,288
| +428,800% | +$45K |
|
3554
Global X Autonomous & Electric Vehicles ETF
DRIV
$338M
| $45K | ﹤0.01% |
1,725
-103
| -6% | -$2.69K |
|
3555
Immersion
IMMR
$222M
| $45K | ﹤0.01% |
6,367
-27,864
| -81% | -$197K |
|
3556
SEALSQ Corp
LAES
$370M
| $45K | ﹤0.01% |
+1,105
| New | +$45K |
|
3557
P3 Health Partners
PIII
$28.5M
| $45K | ﹤0.01% |
309
+69
| +29% | +$10K |
|
|
BHIL
3558
DELISTED
Benson Hill, Inc.
BHIL
| $45K | ﹤0.01% |
1,003
-1,478
| -60% | -$66.3K |
|
3559
iShares MSCI EAFE Value ETF
EFV
$28B
| $44K | ﹤0.01% |
890
| – | – |
|
3560
GSK
GSK
$81.7B
| $44K | ﹤0.01% |
1,226
-83,180
| -99% | -$2.99M |
|
3561
KalVista Pharmaceuticals
KALV
$788M
| $44K | ﹤0.01% |
4,906
-7,507
| -60% | -$67.3K |
|
3562
Nathan's Famous
NATH
$431M
| $44K | ﹤0.01% |
566
-655
| -54% | -$50.9K |
|
3563
FiscalNote
NOTE
$73.5M
| $44K | ﹤0.01% |
1,030
-2,763
| -73% | -$118K |
|
3564
Oculis Holding
OCS
$905M
| $44K | ﹤0.01% |
+3,602
| New | +$44K |
|
3565
374Water
SCWO
$58.4M
| $44K | ﹤0.01% |
+18,735
| New | +$44K |
|
3566
Suburban Propane Partners
SPH
$1.21B
| $44K | ﹤0.01% |
2,968
-265
| -8% | -$3.93K |
|
|
KNTE
3567
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $44K | ﹤0.01% |
14,568
-14,857
| -50% | -$44.9K |
|
|
SCU
3568
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $44K | ﹤0.01% |
4,979
-7,608
| -60% | -$67.2K |
|
|
THRN
3569
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $44K | ﹤0.01% |
9,396
-4,365
| -32% | -$20.4K |
|
3570
iShares Asia 50 ETF
AIA
$979M
| $43K | ﹤0.01% |
725
| – | – |
|
3571
Douglas Elliman
DOUG
$232M
| $43K | ﹤0.01% |
19,254
-21,778
| -53% | -$48.6K |
|
3572
Harvard Bioscience
HBIO
$20.2M
| $43K | ﹤0.01% |
+7,832
| New | +$43K |
|
3573
Holley
HLLY
$369M
| $43K | ﹤0.01% |
10,514
-15,602
| -60% | -$63.8K |
|
3574
Immunovant
IMVT
$2.84B
| $43K | ﹤0.01% |
2,286
+2,200
| +2,558% | +$41.4K |
|
3575
Norwood Financial Corp
NWFL
$245M
| $43K | ﹤0.01% |
1,476
+565
| +62% | +$16.5K |
|